{"SPADE_N_13822": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_13822", "Peptide Name": "Nv-CATH (N. ventripunctata cathelicidin, natural AMPs; frog, amphibians, animals; BBL; 1S=S, UCSS1a)", "Source": "Skin,  the frog,Nanorana ventripunctata, Yunnan, China, Asia", "Family": "Not found", "Gene": "Not found", "Sequence": "NCNFLCKVKQRLRSVSSTSHIGMAIPRPRG", "Sequence Length": 30, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anti-inflammatory", "anti-sepsis"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 3356.95, "PI": 11.56, "Hydrophobicity": -0.36, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Shi J, Wu J, Chen Q, Shen Y, Mi K, Yang H, Mu L. 2022", "Reference": "ACS Infect Dis. 2022 Dec 9;8(12):2464-2479. doi: 10.1021/acsinfecdis.2c00260.PubMed", "Title": "A Frog-Derived Cathelicidin Peptide with Dual Antimicrobial and Immunomodulatory Activities Effectively Ameliorates Staphylococcus aureus-Induced Peritonitis in Mice"}], "Frequent Amino Acids": "RSC", "Absent Amino Acids": "DEOUWY", "Basic Residues": 7, "Acidic Residues": 0, "Hydrophobic Residues": 11, "Polar Residues": 20, "Positive Residues": 7, "Negative Residues": 0, "Net Charge": 7, "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (54.84%) tofrog Cathelicidin-PYGRAVY: -0.36; Mol Wt: 3356.993; Mol formula: C142H245N47O39S3; Mol ex coeff:  125 (disulfide bond). Potentially one S-S bond.Antimicrobial activity: Active against Gram+ bacteria S. haemolyticus 13A13770 (MIC  3.125 ug/ml), S. aureus ATCC25923 (MIC  12.5 ug/ml), E. faecalis ATCC29212 (MIC 50 ug/ml), Gram- bacteria A. junii 13A15578 (MIC 12.5 ug/mL), K. pneumoniae 0813343 (MIC 25 ug/ml), and Sal. paratyphi A (MIC 50 ug/ml).Anti-inflammatory: Nv-CATH shows dose-dependent suppression of the gene expression of NO, IL-6, TNF-alpha, and IL-1beta induced by 100 ng/mL LPS or Lipoteichoic acid (LTA).Toxicity: not hemo.lytic at 300 ug/ml to rabbit RBC. not toxic to mouse peritoneal macrophage (MPMs) and bone-marrow-derived neutrophils (BMDNs) at 100 ug/ml.Animal model:mouse: Nv-CATH (10 mg/kg) significantly protected mice from lethal infections caused by IP-injected S. aureus.", "Similar Sequences": [{"SPADE_ID": "SPADE_N_05691", "Similarity": 0.6071428571428571, "Sequence": "RKCNFLCKLKEKLRTVITSHIDKVLRPQG"}, {"SPADE_ID": "SPADE_UN_25445", "Similarity": 0.6071428571428571, "Sequence": "RKCNFLCKLKEKLRTVITSHIDKVLRPQG"}, {"SPADE_ID": "SPADE_N_09808", "Similarity": 0.5714285714285714, "Sequence": "RLPRPRPRPLPFPRPG"}]}}}